Renostypricin
Brand names,
Renostypricin
Analogs
Renostypricin
Brand Names Mixture
Renostypricin
Chemical_Formula
C9H13NO3
Renostypricin
RX_link
http://www.rxlist.com/cgi/generic3/epi.htm
Renostypricin
fda sheet
Renostypricin
msds (material safety sheet)
Renostypricin
Synthesis Reference
Stolz, Ber. 37, 4149; Payne, Ind. Chem. 37, 523
Renostypricin
Molecular Weight
183.204 g/mol
Renostypricin
Melting Point
211.5 oC
Renostypricin
H2O Solubility
180 mg/L
Renostypricin
State
Solid
Renostypricin
LogP
0.256
Renostypricin
Dosage Forms
Cord; Drops; Liquid; Metered-dose (aerosol); Pad; Pellet; Pellet (dental); Solution; Spray
Renostypricin
Indication
For the treatment of anaphylactic reactions
Renostypricin
Pharmacology
Epinephrine is indicated for intravenous injection in treatment of acute hypersensitivity, treatment of acute asthmatic attacks to relieve bronchospasm, and treatment and prophylaxis of cardiac arrest and attacks of transitory atrioventricular heart block with syncopal seizures (Stokes-Adams Syndrome). The actions of epinephrine resemble the effects of stimulation of adrenergic nerves. To a variable degree it acts on both alpha and beta receptor sites of sympathetic effector cells. Its most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle. When given by rapid intravenous injection, it produces a rapid rise in blood pressure, mainly systolic, by (1) direct stimulation of cardiac muscle which increases the strength of ventricular contraction, (2) increasing the heart rate and (3) constriction of the arterioles in the skin, mucosa and splanchnic areas of the circulation. When given by slow intravenous injection, epinephrine usually produces only a moderate rise in systolic and a fall in diastolic pressure. Although some increase in pulse pressure occurs, there is usually no great elevation in mean blood pressure. Accordingly, the compensatory reflex mechanisms that come into play with a pronounced increase in blood pressure do not antagonize the direct cardiac actions of epinephrine as much as with catecholamines that have a predominant action on alpha receptors.
Renostypricin
Absorption
Usually this vasodilator effect of the drug on the circulation predominates so that the modest rise in systolic pressure which follows slow injection or absorption is mainly the result of direct cardiac stimulation and increase in cardiac output.
Renostypricin
side effects and Toxicity
Skin, LD50 = 62 mg/kg (rat)
Renostypricin
Patient Information
No information avaliable
Renostypricin
Organisms Affected
Humans and other mammals